Retatrutide
Retatrutide is a well-defined synthetic peptide commonly used in peptide characterization, analytical studies, and laboratory research protocols. Provided as a research-grade material, it supports experimental workflows that require standardized peptide composition and reliable batch-to-batch consistency.
Product Name : Retatrutide
Type : Synthetic peptide
Form : Lyophilized powder
Size : 10 Vials
Specifications : 20mg
Grade : Research Use Only (RUO)
Application : Laboratory and experimental research
Product Name : Retatrutide
Type : Synthetic peptide
Form : Lyophilized powder
Size : 10 Vials
Specifications : 20mg
Grade : Research Use Only (RUO)
Application : Laboratory and experimental research
Référence interne:
mGEN-retatrutide
Size:
10 Vials
Retatrutide is an investigational, once-weekly injectable "triple-agonist" medication developed for obesity and type 2 diabetes. By targeting GLP-1, GIP, and glucagon receptors, it has shown superior weight loss results in trials, with phase 3 trials expected to finish in early 2026 and potential FDA approval by 2027